اسهم للمتابعه اليوم والمضاربه

FreeTrader

عضو محترف
التسجيل
15 سبتمبر 2005
المشاركات
9,705
الإقامة
الكويت
تابعو شرعيتهم لا اعلم عنها شي

ARNA

6/13/2006 8:14:50 AM Arena Pharmaceuticals (ARNA) reported results from a Phase IIb study of clinical trial of lorcaserin hydrochloride, for the treatment of obesity, after the close on Monday. The results showed that patients treated with lorcaserin experienced a highly statistically significant average weight loss and reductions in other physical measures, including body mass index and waist and hip circumference. The stock is now trading higher by 0.74 on 18K shares Tuesday morning on Inet
 

FreeTrader

عضو محترف
التسجيل
15 سبتمبر 2005
المشاركات
9,705
الإقامة
الكويت
GS

6/13/2006 8:44:58 AM Goldman Sachs Group (GS) reported second quarter EPS of $4.97 Tuesday morning, compared to the $1.71 reported last year. The consensus estimate was for EPS of $4.19. Revenues surged to $10.1 billion, from the $4.81 billion posted during the prior year quarter. The stock is now trading higher by 0.83 on 34K shares on Inet.
 

FreeTrader

عضو محترف
التسجيل
15 سبتمبر 2005
المشاركات
9,705
الإقامة
الكويت
BBY

6/13/2006 8:10:07 AM Best Buy Co. (BBY) reported first quarter EPS of $0.47 Tuesday morning, compared to the $0.34 reported last year. The consensus estimate was for EPS of $0.36. Revenues rose to nearly $7 billion, from the $6.1 million reported during the prior year quarter. The stock is now trading higher by 1.27 on 2K shares on Inet.
 

FreeTrader

عضو محترف
التسجيل
15 سبتمبر 2005
المشاركات
9,705
الإقامة
الكويت
MVK

6/13/2006 7:42:46 AM Maverick Tube Corp. (MVK) announced Tuesday morning that it had agreed to be acquired by Tenaris SA (TS) for $65 per share in cash, approximately $3.19 billion including the assumption of debt
 

wasmi_6

عضو مميز
التسجيل
6 مارس 2004
المشاركات
3,378
الإقامة
الكويت
شرعي ابو ابراهيم سهمك
 

wasmi_6

عضو مميز
التسجيل
6 مارس 2004
المشاركات
3,378
الإقامة
الكويت
FreeTrader قال:
تابعو شرعيتهم لا اعلم عنها شي

ARNA

6/13/2006 8:14:50 AM Arena Pharmaceuticals (ARNA) reported results from a Phase IIb study of clinical trial of lorcaserin hydrochloride, for the treatment of obesity, after the close on Monday. The results showed that patients treated with lorcaserin experienced a highly statistically significant average weight loss and reductions in other physical measures, including body mass index and waist and hip circumference. The stock is now trading higher by 0.74 on 18K shares Tuesday morning on Inet
اللاست 12.83
الحين اعتقد حلو سعره
 
أعلى